Acute plasma amylase increase after glucagon-like peptide -1 receptor agonist exenatide administration in Type 2 diabetes

2017-04-01

Additional Metadata
Persistent URL	doi.org/10.1111/dme.13160, hdl.handle.net/1765/98624
Journal	Diabetic Medicine: journal of diabetes UK
Grant	This work was funded by the European Commission 7th Framework Programme; grant id fp7/282521 - Safety Evaluation of Adverse Reactions in Diabetes (SAFEGUARD)
Organisation	Department of Gastroenterology & Hepatology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Smits, M. M., Tonneijck, L., Muskiet, M. H. A., Diamant, M., Kramer, M. H. H., Cahen, D., & van Raalte, D. H. (2017). Acute plasma amylase increase after glucagon-like peptide -1 receptor agonist exenatide administration in Type 2 diabetes. Diabetic Medicine: journal of diabetes UK, 34(4), 591–592. doi:10.1111/dme.13160

Publication